Well-characterized Photoreceptor Progenitor Cells (PRP) generated from human induced pluripotent stem cells (TC-1133) employing Eyestem’s patented and published in-house differentiation protocol and immortalized at intermediate stage by transfecting hTERT, SV40 and rtTA genes.
Well-characterized working cell Bank (WCB) of the NCL1 line (induced pluripotent stem cells reprogrammed from CD34+ umbilical cord blood cells under GMP conditions employing integration-free technology by introducing Yamanaka factors) grown and cryoprserved at Eyestem under license from a sample originally distributed for the NIH by RUCDR Infinite Biologics.
Well-characterized working cell Bank (WCB) of the GFP-expressing NCL1 line (induced pluripotent stem cells reprogrammed from CD34+ umbilical cord blood cells under GMP conditions employing integration-free technology by introducing Yamanaka factors) grown and cryopreserved at Eyestem under license from a sample originally distributed for the NIH by RUCDR Infinite Biologics.
Well-characterized Retinal Pigment Epithelium (RPE) cells generated from human induced pluripotent stem cells (TC-1133) employing Eyestem’s clinical-grade differentiation protocol. These cryopreserved cells have been tested for safety and efficacy studies in animal models.